Is Vertex Pharmaceuticals stock a buy now?
Vertex Pharmaceuticals Incorporated VRTX is a good stock to own. There are several reasons to own the stock. Good Rank and Rising Estimates: Vertex has a Zacks Rank #2 (Buy). You can see the ...
What is the price of target stock?
The price target of a stock is the price at which the stock is fairly valued with respect to its historical and projected earnings. When stocks are trading below and above their price targets, investors can maximize their rates of return by buying and selling. Stock price targets are often published by research analysts.
What is target stock price?
The stock has a market cap of $20.58 billion, a price-to-earnings ratio of 875.81, a PEG ratio of 2.71 and a beta of 1.25. ZoomInfo Technologies has a fifty-two week low of $37.86 and a fifty-two week high of $79.17.
What is target share price?
Three of SPXV's underlying holdings with notable upside to their analyst target prices are AMETEK Inc (Symbol: AME), Verisign Inc (Symbol: VRSN), and Trimble Inc (Symbol: TRMB). Although AME has traded at a recent price of $144.06/share, the average ...
See more
Is Vertex a buy or sell?
Vertex Pharmaceuticals has received a consensus rating of Buy. The company's average rating score is 2.63, and is based on 10 buy ratings, 6 hold ratings, and no sell ratings.
Is Vertex undervalued?
Enterprise Value is likely to rise to about 17.8 B in 2022. Vertex Pharmaceutic has a current Real Value of $267.57 per share. The regular price of the company is $288.81. At this time, the company appears to be overvalued.
Will Vertex pay a dividend?
Vertex Pharmaceuticals (NASDAQ: VRTX) does not pay a dividend.
Is Vertex publicly traded?
The Company went public in 1991. What exchange is Vertex stock listed on? What is Vertex's stock symbol? Vertex is listed on The Nasdaq National Market under the ticker symbol VRTX.
Is Vertex a good buy?
Good Rank and Rising Estimates: Vertex has a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Vertex's stock has declined 2.5% in the past year compared with the industry's decline of 37%.
Will Vertex stock recover?
Based on our forecasts, a long-term increase is expected, the "VRTX" stock price prognosis for 2027-06-30 is 358.257 USD. With a 5-year investment, the revenue is expected to be around +24.69%. Your current $100 investment may be up to $124.69 in 2027. Get It Now!
How do you buy a stock Vertex?
How to buy shares in Vertex PharmaceuticalsCompare share trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
What company owns vertex?
Vertex was founded in 1978 by Ray Westphal. Jeff Westphal, Stevie Westphal Thompson and Amanda Westphal Radcliffe purchased interest in the company from their father in 2000. On July 29, 2020, the company went public on the Nasdaq stock exchange....Vertex Inc.TypePublicWebsiteVertex11 more rows
Who took Vertex public?
was founded in 1978 by Ray and Antoinette Westphal. Their children, Jeff Westphal, Stevie Westphal Thompson and Amanda Westphal Radcliffe, purchased the company in 2000. They serve on the board and control most of Vertex's Class B voting shares. The decision to pursue an IPO was reached in early to mid-2019.
Should I buy or sell Vertex Pharmaceuticals stock right now?
15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Vertex Pharmaceuticals in the last twelve months. There are currently 7 h...
What is Vertex Pharmaceuticals' stock price forecast for 2022?
15 brokers have issued 12-month price targets for Vertex Pharmaceuticals' shares. Their VRTX stock forecasts range from $222.00 to $350.00. On aver...
How has Vertex Pharmaceuticals' stock performed in 2022?
Vertex Pharmaceuticals' stock was trading at $219.60 at the start of the year. Since then, VRTX shares have increased by 16.1% and is now trading a...
When is Vertex Pharmaceuticals' next earnings date?
Vertex Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022. View our earnings forecast f...
How were Vertex Pharmaceuticals' earnings last quarter?
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) posted its quarterly earnings data on Thursday, May, 5th. The pharmaceutical company reported $3....
What guidance has Vertex Pharmaceuticals issued on next quarter's earnings?
Vertex Pharmaceuticals issued an update on its FY 2022 earnings guidance on Monday, May, 23rd. The company provided earnings per share (EPS) guidan...
Who are Vertex Pharmaceuticals' key executives?
Vertex Pharmaceuticals' management team includes the following people: Dr. Reshma Kewalramani FASN , M.D., CEO, Pres & Director (Age 49, Pay $4....
What is Reshma Kewalramani's approval rating as Vertex Pharmaceuticals' CEO?
31 employees have rated Vertex Pharmaceuticals CEO Reshma Kewalramani on Glassdoor.com . Reshma Kewalramani has an approval rating of 76% among Ve...
Who are some of Vertex Pharmaceuticals' key competitors?
Some companies that are related to Vertex Pharmaceuticals include Amgen (AMGN) , Gilead Sciences (GILD) , Regeneron Pharmaceuticals (REGN) , Bi...
Is VERX stock a buy right now?
6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Vertex in the last twelve months. There are currently 1 sell rati...
Will Vertex's stock price go up in 2022?
6 equities research analysts have issued 12-month price objectives for Vertex's shares. Their forecasts range from $13.50 to $28.00. On average, th...
How has Vertex's stock price performed in 2022?
Vertex's stock was trading at $15.87 on January 1st, 2022. Since then, VERX shares have decreased by 28.9% and is now trading at $11.29. View the...
When is Vertex's next earnings date?
Vertex is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022. View our earnings forecast for Vertex .
How were Vertex's earnings last quarter?
Vertex, Inc. (NASDAQ:VERX) released its quarterly earnings data on Tuesday, May, 10th. The company reported $0.08 EPS for the quarter, topping the...
What guidance has Vertex issued on next quarter's earnings?
Vertex updated its second quarter 2022 earnings guidance on Tuesday, June, 7th. The company provided earnings per share guidance of for the period....
Who are Vertex's key executives?
Vertex's management team includes the following people: Mr. David DeStefano , CEO, Pres & Chairman (Age 59, Pay $1.61M) Ms. Amanda Westphal Radc...
Who are some of Vertex's key competitors?
Some companies that are related to Vertex include Guidewire Software (GWRE) , Ubisoft Entertainment (UBSFY) , Procore Technologies (PCOR) , Mar...
What other stocks do shareholders of Vertex own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Vertex investors own include Adobe (ADBE) , BigCommerce (...
Where is Vertex located?
What is Vertex Taxamo?
Headquartered in North America, and with offices in South America and Europe, Vertex employs over 1,200 professionals and serves companies across the globe. For more information, visit www.vertexinc.com or follow on Twitter and LinkedIn. Copyright © 2021 Vertex, Inc. All rights reserved.
When is Vertex's 10K due?
(NASDAQ:VERX) and its subsidiaries, (“Vertex” or the “Company”), a global provider of tax technology solutions, announced its Taxamo Assure by Vertex® solution that facilitates and enhances the successful completion of online sales by e-commerce sellers. The Assure solution enables such sellers to ensure that their covered sales are in full compliance with the complex process of value-added tax (VAT) calculation and reporting o
Is Taxamo part of Vertex?
Additional factors that could cause actual results to differ materially from these forward-looking statements are detailed from time to time in the reports Vertex files with the Securities and Exchange Commission, including in its Annual Report on Form 10-K for the fiscal year ended December 31, 2020.
When will Vertex Pharmaceuticals buy back its stock?
Taxamo solutions are expected to be integrated into the Vertex cloud portfolio, bringing new capabilities and expanded digital content to Vertex’s large, global customer base. Taxamo founder and CEO John McCarthy joins Vertex in a senior leadership role overseeing the company’s global e-commerce and marketplace strategy.
How much does Vertex Pharmaceuticals make?
How will Vertex Pharmaceuticals' stock buyback program work? Vertex Pharmaceuticals declared that its board has approved a stock repurchase program on Wednesday, July 31st 2019 , which authorizes the company to buyback $500,000,000.00 in shares, according to EventVestor.
When is the earnings conference call for Vertex?
Vertex Pharmaceuticals has a market capitalization of $51.90 billion and generates $6.21 billion in revenue each year. The pharmaceutical company earns $2.71 billion in net income (profit) each year or $9.03 on an earnings per share basis.
Is Vertex a hold stock?
How can I listen to Vertex's earnings call? Vertex will be holding an earnings conference call on Wednesday, August 11th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13721451".
Recently Viewed Tickers
Wall Street analysts have given Vertex a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Vertex wasn't one of them.
Vertex Inc. Cl A
Visit a quote page and your recently viewed tickers will be displayed here.
What is a vertex?
Vertex, Inc. engages in the provision of tax compliance software solutions. The firm offers comprehensive solutions that automate end-to-end indirect tax processes for enterprises and mid-market companies with complex tax transactions. Its software enables tax determination, data management, compliance and reporting, and document management.
Where is Vertex located?
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Vertex, Incorporated is a tax compliance software and services company based in King of Prussia, Pennsylvania, USA. Vertex was founded in 1978 by Ray Westphal.
About Vertex Energy
Vertex, Incorporated is a tax compliance software and services company based in King of Prussia, Pennsylvania, USA . Vertex was founded in 1978 by Ray Westphal. Jeff Westphal, Stevie Westphal Thompson and Amanda Westphal Radcliffe purchased interest in the company from their father in 2000.
Headlines
Vertex Energy, Inc. engages in the recycle of industrial waste streams and off-specification commercial chemical products. The firm focuses on the recycle of used motor oil and other petroleum by-products. It operates through the following segments: Black Oil, Refining and Marketing and Recovery.
Vertex Energy (NASDAQ:VTNR) Frequently Asked Questions
Thinking about buying stock in Palantir Technologies, Matterport, Fastly, Kinross Gold, or Vertex Energy?
